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PROTEOMIC AND BIOINFORMATIC ANALYSIS OF HYDROPHOBIC
MEMBRANE PROTEIN EXTRACTS REVEALS THE PRESENCE OF
SEVERAL NOVEL CD ANTIGENS, GLUCOSE TRANSPORTERS AND
VOLTAGE GATED ANION CHANNELS IN ARTICULAR CHONDROCYTES
S. Liddell 1, J.R. Smith 2, X. Zhang 1, H. Hall 1, A. Swan 1, J. Bacardit 1,
A. Mobasheri 1. 1Univ. of Nottingham, Sutton Bonington, United Kingdom;
2Bruker UK, Coventry, United Kingdom
Purpose:Membrane proteins are a key interface between the interior and
exterior of living cells. In chondrocytes they perform many important
cellular functions including cell-matrix interactions, communication,
transport, differentiation and receptor signaling. Membrane proteins are
known targets for many currently available pharmaceuticals. Deﬁning the
membrane proteome of chondrocytes will therefore advance our under-
standing of fundamental biological processes in cartilage and may reveal
new targets for drug discovery efforts. However, the study of plasma
membrane proteins is challenging due to their low abundance, hydro-
phobicity and large size. Proteomic analysis of plasma membrane proteins
by conventional proteomic approaches using 2D-electrophoresis is
particularly problematic. The aim of this study was to develop a detergent-
based separation method to extract membrane proteins from chon-
drocytes and use nanoLC-MS/MS with shotgun and gel-based proteomics
methodologies to identify membrane proteins and validate the expression
of selected proteins using immunoﬂuorescence microscopy.
Methods: Primary cultures of chondrocytes were established from equine
cartilage sourced from a local abattoir. Chondrocytes were released from
cartilage using type I collagenase. To ensure preservation of the chon-
drocyte phenotype, only freshly dissociated, ﬁrst expansion and ﬁrst
passage cells were used. Chondrocyte protein extracts were separated into
hydrophobic and hydrophilic fractions using Triton X-114 phase separa-
tion. Trypsin digested protein fractions were analyzed by LC-MSMS using
Bruker Easy-nanoLC chromatography and a Bruker amaZon ion trap
instrument. The top 5 most abundant peptides from each MS scan were
selected for fragmentation. MS data were submitted to the MASCOT search
engine and compared to entries in the NCBInr database. The sequences of
the proteins identiﬁed were analyzed by CELLO to predict their subcellular
localizations. Proteins were divided into groups based on their predicted
localization and further analyzed with DAVID Bioinformatics Resources.
Features including function, presence in pathways and other associated
proteins were uncovered using DAVID. Immunoﬂuorescence techniques
were used to conﬁrm the expression of selected membrane proteins.
Results: More than 200 proteins were identiﬁed. Analysis of the hydro-
phobic membrane fraction conﬁrmed the presence of several novel
membrane proteins as well as a number of previously described CD anti-
gens, channels and glucose transporters. Table 1 summarizes the identi-
ties, MASCOT scores, locations and biological functions of the proteinsTable 1
Selected hydrophobic membrane proteins identiﬁed in chondrocytes.
Name Score (MASCOT) Location (CELLO)
Voltage gated anion channel 1 (VDAC1) 1157 Mitochondrial outer
Voltage gated anion channel 2 (VDAC2) 594 Mitochondrial outer
Voltage gated anion channel 3 (VDAC3) 368 Mitochondrial outer
CD151 106 Plasma membrane
CD81 92 Plasma membrane
CD63 57 Plasma membrane
Solute carrier family 2 (facilitated glucose
transporter), member 1 - GLUT1
48 Nuclear (CELLO); Ce
membrane (DAVID)
Solute carrier family 2 (facilitated glucose
transporter), member 3 - GLUT3
45 Plasma membrane
CD9 44 Plasma membrane
Solute carrier family 2 (facilitated glucose
transporter), member 14 - GLUT14
34 Plasma membraneidentiﬁed. The immunodetection of the GLUT1 and GLUT3 proteins (Figure
1) conﬁrms previously published reports on the expression and function of
these hypoxia-responsive glucose transporters in chondrocytes. Expres-
sion of GLUT14 (Figure 1), a duplicon of GLUT3 originally cloned from
testis, is a novel observation that provides further evidence for a critical
role for glucose transport and metabolism in chondrocyte biology. Iden-
tiﬁcation of the mitochondrial VDAC channel proteins conﬁrms recent
proteomic data obtained from human cartilage.
Conclusions: In summary, the data presented support the view that the
study of membrane proteins in chondrocytes is feasible using phase
separation and high-throughput LC-MSMS based proteomics. Bio-
informatic tools such as MASCOT, CELLO and DAVID can enhance and
reﬁne this discovery approach by revealing information about the cellular
localization and functions of the proteins identiﬁed. This strategy will help
us learnmore about membrane proteins in chondrocytes andmay prove to




PROTEOMIC CHARACTERISATION AND QUANTIFICATION OF AN IN-
VITRO EARLY EQUINE OSTEOARTHRITIS MODEL
M.J. Peffers 1, R.J. Beynon 2, D. Thornton 3, P.D. Clegg 1. 1Univ. of Liverpool,
Institute of Ageing and Chronic Disease, Liverpool, United Kingdom; 2Univ.
of Liverpool, Institute of Integrative Biology, Liverpool, United Kingdom;
3Univ. of Manchester, Faculty of Life Sciences, Manchester, United Kingdom
Purpose: Osteoarthritis (OA) is characterized by a loss of extracellular
matrix (ECM) which is driven by catabolic cytokine. Proteomic analysis of
the OA cartilage secretome, which provides an important class of active
molecules with roles in numerous pathological mechanisms, allows the
global study of secreted proteins. Although cartilage studies have identi-
ﬁed proﬁles of secreted proteins, limited quantitative proteomics tech-
niques have been implemented which would enable further biological
questions to be addressed. Therefore a cartilage explant model of early OA
employed IL1-b to identify and quantify secreted proteins, whilst also
investigating the cellular mechanisms involved.
Methods: Equine cartilage explants (normal donors n¼8) were incubated
for 5 days alone or in the presence of human recombinant IL-1b. Explants
were lyophilized in order to obtain a dry weight for normalisation. Media
was separated by 1D SDS-PAGE and analysed using LC interfaced with
a linear ion trap quadruple (LTQ) following in-gel tryptic digestion. MediaMolecular Function (DAVID) Biological Function (DAVID)
membrane Pore activity; channel activity;
protein binding
Transport; ion transport;
apoptosis; cell volume control
membrane Pore activity; channel activity;
protein binding
Transport; ion transport
membrane Pore activity; channel activity Transport; ion transport
Protein binding Cell adhesion
Protein binding -
Signal transduction -
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resolved by liquid chromatography-mass spectrometry (LC-MS) using
a linear ion-trap Orbitrap mass spectrometer. Progenesis LC-MS software
(Nonlinear Dynamic) was used for label-free quantiﬁcation with data
searched for protein identiﬁcations using Mascot in the Ensembl database
for horse. Bioinformatics were undertaken for up-regulated and down-
regulated proteins with the enrichment analysis tool of the Con-
sensusPathDB program along with the protein network analysis ‘Search
Tool for Retrieval of Interacting Genes/Proteins’ (STRING) tool.
A cartilage secretome QconCAT was designed and expressed through
recombinant genes in E.coli, cultured in media containing stable isotope
labelled amino acids. The media and QconCATwere reduced, alkylated and
trypsin digested in solution. Quantiﬁcation of cartilage oligomeric matrix
protein and ﬁbromodulin was achieved by comparing the peak area ratios
of heavy (QconCAT) and light (analyte) peptide transitions using a Waters
Xevo-triple quadropole-MS.
Results: 1D SDS PAGE and LC-MS elucidated both qualitative differences
and treatment induced changes in relative protein abundance in the
secretome protein proﬁles of explants models of early OA. We identiﬁed
a total of 295 proteins; 100 differentially expressed in the early OA model.
19% of down-regulated proteins were attributed to ‘ECM’ and 13.8% of up-
regulated proteins to ‘glycolysis’ using gene ontology. Pathway enrichment
analyses conﬁrmed the up-regulation of glycolytic and glucose-related
proteins. Novel proteins clathrin and LIM and SH3 domain protein-1 were
identiﬁed for the ﬁrst time in cartilage proteomics. Cartilage oligomeric
matrix protein increased in the early OA secretome from 3642 to 6505
pmol/g dry weight, but no signiﬁcant change in ﬁbromodulin was
identiﬁed.
Conclusions: A highly sensitive proteomic comparison together with
insightful data mining enabled us to identify proteins and pathways
involved in early OA which could aid the development of early OA diag-
nostic markers and therapeutics.
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INFRAPATELLAR FAT PAD FROM OSTEOARTHRITIS PATIENTS DISPLAYS
A DISTINCTIVE EICOSANOID RELEASE PROFILE COMPARED TO
HEALTHY DONORS
L.M. Gierman 1,2, B. van El 1, A. Hoekstra 1, S. Wopereis 3, E.R. Verheij 3,
B.J. Werff-van der Vat 3, Y.M. Bastiaansen-Jenniskens 4, G.J. van Osch 4,
V. Stojanovic-Susulic 5, M. Kloppenburg 2, T.W. Huizinga 2,
A.-M. Zuurmond 1. 1 TNO, Leiden, Netherlands; 2 Leiden Univ. Med. Ctr., Dept.
of Rheumatology, Leiden, Netherlands; 3 TNO, Zeist, Netherlands; 4 Erasmus
MC. Univ. Med. Ctr. Rotterdam, Rotterdam, Netherlands; 5 Janssen, The
Pharmaceutical companies of Johnson&Johnson, Radnor, PA, USA
Purpose: Obesity, an important risk factor for osteoarthritis (OA), induces
inﬂammatory changes in adipose tissue. The infrapatellar fat pad (IPFP)
present in the knee joint is considered as an active osteoarthritis joint
tissue contributing to local inﬂammatory and destructive processes.
However, soluble mediators released by IPFP involved in these processes
are largely unknown. Eicosanoids are essential mediators of the inﬂam-
matory response and contribute to the initiation and the resolution of
inﬂammation. In this study we aimed to detect differences between
healthy and OA derived IPFP based on their secretion of lipid mediators
involved in the eicosanoid pathway.
Methods: IPFP explants of 13 OA donors (joint replacement surgery) and
11 donors with macroscopically healthy knee joints (post-mortem) were
cultured for 24 hours (50 mg IPFP explant/ml) and the supernatant was
collected. Fat conditioned medium (FCM) samples were measured by an
LC-MS/MS method for lipid mediators of inﬂammation (e.g. oxylipids,
eicosanoids). Data were subjected to univariate and multivariate statistical
analyses.
Results: On an individual basis, lipid mediators involved in the eicosanoid
pathway were not signiﬁcantly different between OA and healthy FCM.
However, when assessed with multivariate statistical analysis (PLS-DA) 14
out of 29 quantiﬁed eicosanoids were found to be important to distinguish
OA from healthy FCM. Lipoxin A4, considered as an important anti-
inﬂammatory oxylipid, was the most discriminative eicosanoid in the
model with lower levels in OA than in healthy FCM. Prostaglandins (PG)
derived from eicosapentaenoic acid (EPA) are generally regarded as anti-inﬂammatory and lower levels of PGD3 were found in OA FCM. In contrary,
no changes in level of EPA were observed. Remarkably, the levels of
docosahexaenoic acid (DHA) and its derived precursor for resolvin D1,
generally regarded as anti-inﬂammatory, were higher in OA FCM. The level
of the fatty acid arachidonic acid (AA), generally regarded as a precursor
for pro-inﬂammatory PG, was higher in OA than in healthy FCM. This was
supported by a higher level of PGF2alfa and PGD2 in OA
FCM. Conversely, AA-derived PGB2 and PGF2beta levels were lower.
Furthermore, OA patients showed increased concentrations of throm-
boxane A2. Linoleic acid-derived eicosanoids 9-HODE and 13-HODE, major
components of ox-LDL and regarded as markers for lipid peroxidation,
were lower in OA. Overall, the differences observed between healthy and
OA FCM could not be attributed to basal metabolism changes, because
downstream products of a certain pathway were differentially affected
(e.g. PG derived from AA).
Conclusions:OA patients can be distinguished from healthy persons based
on their IPFP secretion of lipid mediators involved in the eicosanoid
pathway. However, these differences are small, since none of the distinc-
tive eicosanoids were signiﬁcantly altered on an individual basis. Based on
biological pathway analyses the eicosanoid proﬁle associated with OA is
likely to be speciﬁcally regulated by the disease process rather than due to
basal metabolism changes or generic enzyme alterations. In general, pro-
inﬂammatory eicosanoids appear to be higher and anti-inﬂammatory
appear to be lower in OA than in healthy FCM which strengthens our
hypothesis, but there are exceptions. These data provide new insight in
mechanisms important for the pathogenesis of OA.
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THE PROTEOME OF YOUNG AND HEALTHY HUMAN HAMSTRING
O. Hakimi, N. Ternette, R. Murphy, B. Kessler, A. Carr. Oxford Univ., Oxford,
United Kingdom
Purpose: Despite ongoing research into tendon disease, the exact content
of the extracellular matrix of tendon remains partially described. For
example, only few markers are used for tendon, and the majority of these
are non-speciﬁc. This limits the ability to distinguish tendon cells from
other ﬁbroblasts of the musculoskeletal system and the understanding of
pathological tendon. To date, most studies of tendon phenotype focused on
tendon-derived cells in vitro or animal models such as an acutely inﬂamed
rat Achilles. Thus, the motivation exists to characterize healthy, young,
human tendon. A better inventory of tendon proteins can be used to
identify markers and serve as a comparison for diseased or aging tendon
tissue. Here, we analyzed the protein composition of repeated biopsies
from a single human tendon removed from a young patient undergoing
ACL repair by quantitative tandem mass spectrometry. This study was
designed to test the repeatability of the homogenization, sampling and
analysis, as well as produce a preliminary tendon inventory of healthy,
young human Hamstring.
Methods: Tissue acquisition- Hamstring tissue (the end of an auto-graft)
was collected from a 23 years old male patient undergoing ACL repair.
Approval was obtained from the local Research Ethics Committee. Sample
processing- 4 rice-grain sized samples were cut from the tissue and pro-
cessed individually by suspension in guanidine hydrochloride and
homogenization in a gentleMacs dissociator (Miltenyi Biotec). Proteins
were precipitated using chloroform/methanol and digested with trypsin.
Peptides were puriﬁed using a C18 Sep-pak column (Waters). Sample
analysis- Equal amounts of peptide material were analyzed by UPLC
(nanoAquity, Waters) online coupled to an LTQ Orbitrap Velos (Thermo
Scientiﬁc). Peptides were eluted by applying a 180 min linear gradient
from 3% buffer A (0.1% formic acid in water) to 40% buffer B (0.1% formic
acid in acetonitrile) on a C18 column (waters). Higher-energy C-trap
dissociation (HCD) was induced on the ten most abundant ions per full MS
scan. Data analysis- All samples were analyzed in triplicates. Identiﬁcation
and quantitation was performed using MASCOT (v2.3.01) derived emPAI
values.
Results: Overall, 244 proteins were identiﬁed. The variation of the tech-
nical repeats (within each biopsy) was small, as demonstrated by the Venn
diagrams (Figure 1), conﬁrming the accuracy of the instrumentations as
well as the homogeneity of the samples. Furthermore, the relatively small
variation between the biopsies of the sample tendon (Figure 1D) points to
